Chiara Mazzarelli

1.8k total citations
39 papers, 398 citations indexed

About

Chiara Mazzarelli is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Chiara Mazzarelli has authored 39 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 24 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Chiara Mazzarelli's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (19 papers) and Liver Disease and Transplantation (10 papers). Chiara Mazzarelli is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (19 papers) and Liver Disease and Transplantation (10 papers). Chiara Mazzarelli collaborates with scholars based in Italy, United Kingdom and United States. Chiara Mazzarelli's co-authors include L Belli, Antonio Picardi, Umberto Vespasiani‐Gentilucci, Mary Cannon, Giovanni Galati, Giuseppe Perrone, Andrea Onetti Muda, Simone Carotti, S. Morini and Kosh Agarwal and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Journal of Hepatology.

In The Last Decade

Chiara Mazzarelli

34 papers receiving 387 citations

Peers

Chiara Mazzarelli
Jamak Modaresi Esfeh United States
Sylvia Dražilová Slovakia
C. Stehman-Breen United States
U. Warzocha France
Kendall Beck United States
Seong Eon Yoon South Korea
K. Linda Tang United States
Zita Galvin Canada
Donna R. Cryer United States
Anil B. Seetharam United States
Jamak Modaresi Esfeh United States
Chiara Mazzarelli
Citations per year, relative to Chiara Mazzarelli Chiara Mazzarelli (= 1×) peers Jamak Modaresi Esfeh

Countries citing papers authored by Chiara Mazzarelli

Since Specialization
Citations

This map shows the geographic impact of Chiara Mazzarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Mazzarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Mazzarelli more than expected).

Fields of papers citing papers by Chiara Mazzarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Mazzarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Mazzarelli. The network helps show where Chiara Mazzarelli may publish in the future.

Co-authorship network of co-authors of Chiara Mazzarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Mazzarelli. A scholar is included among the top collaborators of Chiara Mazzarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Mazzarelli. Chiara Mazzarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stella, Leonardo, Fabio Marra, Chiara Mazzarelli, et al.. (2025). Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab- Bevacizumab for hepatocellular carcinoma. Digestive and Liver Disease. 57. S24–S25. 1 indexed citations
3.
Becchetti, Chiara, Miki Scaravaglio, Mauro Orlando, et al.. (2025). Challenges in the management of MetALD after liver transplantation. 5(1).
4.
Patelli, Giorgio, Federica Villa, Nicole Gri, et al.. (2025). Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review. Cancer Treatment Reviews. 135. 102908–102908. 5 indexed citations
5.
Tabrizian, Parissa, Rebecca Marino, Sherrie Bhoori, et al.. (2024). Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma. JHEP Reports. 7(2). 101246–101246. 6 indexed citations
6.
Becchetti, Chiara, Chiara Mazzarelli, Lucia Cesarini, et al.. (2024). Statin therapy: improving survival in patients with hepatocellular carcinoma and portal hypertension is possible?. Acta Gastro Enterologica Belgica. 87(3). 395–402. 1 indexed citations
7.
Carbone, Marco, Chiara Mazzarelli, Eléonora De Martin, et al.. (2023). Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement. Transplant International. 36. 11729–11729. 8 indexed citations
8.
Mazzarelli, Chiara, et al.. (2022). Implementation of the frailty assessment to improve liver transplant outcomes. Aging Clinical and Experimental Research. 34(8). 1919–1923. 3 indexed citations
9.
Manini, M.A., Matthew Bruce, Gavin Whitehouse, et al.. (2020). A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients. Transplantation Proceedings. 53(1). 207–214. 4 indexed citations
10.
Mazzarelli, Chiara, Raffaella Viganò, Marcello Vangeli, & Angelo Vanzulli. (2020). An atypical presentation of biliary cast syndrome (BCS). Digestive and Liver Disease. 53(8). 1050–1050.
11.
Perricone, Giovanni, Christophe Duvoux, Marina Berenguer, et al.. (2018). Delisting HCV‐infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting. Liver International. 38(12). 2170–2177. 46 indexed citations
12.
Cortesi, Paolo Angelo, L Belli, Rita Facchetti, et al.. (2018). The optimal timing of hepatitis C therapy in liver transplant‐eligible patients: Cost‐effectiveness analysis of new opportunities. Journal of Viral Hepatitis. 25(7). 791–801. 18 indexed citations
13.
Mazzarelli, Chiara, Wendy Prentice, Michael A. Heneghan, et al.. (2018). Palliative care in end‐stage liver disease: Time to do better?. Liver Transplantation. 24(7). 961–968. 43 indexed citations
14.
Martini, Silvia, Maria Francesca Donato, Chiara Mazzarelli, et al.. (2017). The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real‐life experience. Liver International. 38(4). 733–741. 8 indexed citations
15.
Donato, Maria Francesca, Maria Cristina Morelli, Renato Romagnoli, et al.. (2016). Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre‐ to post‐liver transplant: a real‐life strategy. Liver International. 37(5). 678–683. 9 indexed citations
16.
Cortesi, Paolo Angelo, LG Mantovani, Antonio Ciaccio, et al.. (2015). Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis. American Journal of Transplantation. 15(7). 1817–1826. 15 indexed citations
17.
Perricone, Giovanni & Chiara Mazzarelli. (2014). Reexpansion Pulmonary Edema after Thoracentesis. New England Journal of Medicine. 370(12). e19–e19. 3 indexed citations
18.
Caremani, Marcello, et al.. (2013). Focal splenic lesions: US findings. Journal of Ultrasound. 16(2). 65–74. 38 indexed citations
19.
Vespasiani‐Gentilucci, Umberto, Antonio De Vincentis, Giovanni Galati, et al.. (2012). 1288 NAFLD FIBROSIS SCORE IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING CORONAROGRAPHY. Journal of Hepatology. 56. S508–S508. 1 indexed citations
20.
Vespasiani‐Gentilucci, Umberto, Giovanni Galati, Chiara Mazzarelli, et al.. (2010). Angiogenic Cytokines in Patients Undergoing Antiviral Treatment for Chronic Hepatitis C Virus Infection. Journal of Interferon & Cytokine Research. 31(2). 207–210. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamak Modaresi Esfeh Breakdown of academic impact, for papers by Sylvia Dražilová Breakdown of academic impact, for papers by C. Stehman-Breen Breakdown of academic impact, for papers by U. Warzocha Breakdown of academic impact, for papers by Kendall Beck Breakdown of academic impact, for papers by Seong Eon Yoon Breakdown of academic impact, for papers by K. Linda Tang Breakdown of academic impact, for papers by Zita Galvin Breakdown of academic impact, for papers by Donna R. Cryer Breakdown of academic impact, for papers by Anil B. Seetharam
Rankless by CCL
2026